Omega Healthcare Investors Inc (OHI) financial statements: income statement, balance sheet and cash flow

Omega Healthcare Investors Inc's income statement, balance sheet and cash flow statement as filed with the SEC (10-K and 10-Q), with the latest fiscal years and quarters. In its latest fiscal year (Dec 31, 2025 · FY), Omega Healthcare Investors Inc reported revenue of $1.2B (+13.2% year on year) and net income of $609.5M (+45.9% year on year).

Income statement

Omega Healthcare Investors Inc income statement, fiscal years

Line item	Dec 31, 2025 · FY	Dec 31, 2024 · FY	Dec 31, 2023 · FY	Dec 31, 2022 · FY
Rental income	$1.0B	$887.9M	$825.4M	$750.2M
Interest income	$175.1M	$157.2M	$119.9M	$123.9M
Miscellaneous income	$13.0M	$6.3M	$3.5M	$3.1M
Total revenues	$1.2B	$1.1B	$949.7M	$878.2M
Depreciation and amortization	$325.2M	$304.6M	$319.7M	$332.4M
General and administrative	$104.1M	$88.0M	$81.5M	$69.4M
Real estate taxes	$14.4M	$14.6M	$15.0M	$15.5M
Acquisition, merger and transition related costs	$4.2M	$11.6M	$5.3M	$42.0M
Impairment on real estate properties	$22.6M	$23.8M	$91.9M	$38.5M
Provision (recovery) for credit losses	$2.3M	($15.5M)	$44.6M	$68.7M
Interest Expense	$215.0M	$221.7M	$235.5M	$233.2M
Total expenses	$688.0M	$648.9M	$793.6M	$799.7M
Other income - net	$50.1M	$6.8M	$20.3M	($2.0M)
Gain (loss) on debt extinguishment	$5.0M	($1.7M)	($492.0K)	($389.0K)
Gain on assets sold - net	$67.3M	$13.2M	$79.7M	$360.0M
Total other income	$122.4M	$18.2M	$99.5M	$357.6M
Income before income tax expense and income from unconsolidated entities	$624.4M	$420.7M	$255.6M	$436.1M
Income tax expense	($14.7M)	($10.9M)	($6.3M)	($4.6M)
(Loss) income from unconsolidated entities	($218.0K)	$7.9M	($582.0K)	$7.3M
Net income	$609.5M	$417.8M	$248.8M	$438.8M
Net income attributable to noncontrolling interest	($19.3M)	($11.5M)	($6.6M)	($11.9M)
Net income available to common stockholders	$590.2M	$406.3M	$242.2M	$426.9M
Net income available to common stockholders	$1.96	$1.57	$1.01	$1.81
Net income available to common stockholders	$1.94	$1.55	$1.00	$1.80

Omega Healthcare Investors Inc income statement, quarters

Line item	Jun 30, 2026 · Q2	Mar 31, 2026 · Q1	Sep 30, 2025 · Q3	Jun 30, 2025 · Q2
Rental income	$266.5M	$270.6M	$264.5M	$239.2M
Interest income	$46.8M	$45.2M	$44.8M	$43.0M
Resident fees and services	$14.0M	$6.7M	—	—
Miscellaneous income	$1.0M	$526.0K	$2.2M	$307.0K
Total revenues	$328.2M	$323.0M	$311.6M	$282.5M
Depreciation and amortization	$81.8M	$84.1M	$82.1M	$80.5M
Interest Expense	$48.1M	$49.8M	$58.1M	$52.9M
Property-level expenses	$16.2M	$5.4M	—	—
General and administrative	$42.0M	$26.0M	$23.8M	$23.8M
Acquisition, merger and transition related costs	$4.7M	$1.1M	$593.0K	$2.0M
Impairment on real estate properties	$0	$392.0K	$1.1M	$14.2M
(Recovery) provision for credit losses	($5.0M)	($3.3M)	($3.9M)	($4.8M)
Total expenses	$187.8M	$167.1M	$165.3M	$171.9M
Other (expense) income - net	($7.2M)	$1.1M	$16.8M	$13.8M
Gain on assets sold - net	$246.5M	$3.0M	$28.3M	$22.9M
Total other income	$239.3M	$4.1M	$45.1M	$36.6M
Income before income tax expense and income (loss) from unconsolidated entities	$379.8M	$159.9M	$191.3M	$147.2M
Income tax expense	($4.6M)	($5.1M)	($4.5M)	($4.5M)
Income (loss) from unconsolidated entities	$4.5M	$3.8M	($1.9M)	($2.2M)
Net income	$379.7M	$158.6M	$185.0M	$140.5M
Net income attributable to noncontrolling interest	($16.8M)	($7.5M)	($5.2M)	($3.9M)
Net income available to common stockholders	$362.8M	$151.0M	$179.7M	$136.6M
Net income available to common stockholders	$1.21	$0.47	$0.60	$0.46
Net income available to common stockholders	$1.19	$0.47	$0.59	$0.46

Balance sheet

Omega Healthcare Investors Inc balance sheet, fiscal years

Line item	Dec 31, 2025 · FY	Dec 31, 2024 · FY	Dec 31, 2023 · FY	Dec 31, 2022 · FY
Buildings and improvements	$7.9B	$7.3B	$6.9B	$7.3B
Land	$1.2B	$996.7M	$866.9M	$923.6M
Furniture and equipment	$539.8M	$510.1M	$466.3M	$499.9M
Construction in progress	$12.5M	$210.9M	$138.4M	$88.9M
Total real estate assets	$9.6B	$9.1B	$8.3B	$8.9B
Less accumulated depreciation	($2.9B)	($2.7B)	($2.5B)	($2.3B)
Real estate assets - net	$6.7B	$6.3B	$5.9B	$6.5B
Real estate loans receivable - net	$1.4B	$1.4B	$1.2B	$1.0B
Investments in unconsolidated entities	$414.1M	$88.7M	$188.4M	$178.9M
Assets held for sale	$4.0M	$56.2M	$93.7M	$9.5M
Total real estate investments	$8.5B	$7.9B	$7.4B	$7.8B
Non-real estate loans receivable - net	$330.3M	$332.3M	$275.6M	$225.3M
Total investments	$8.8B	$8.3B	$7.7B	$8.0B
Cash and cash equivalents	$27.0M	$518.3M	$442.8M	$297.1M
Restricted cash	$27.5M	$30.4M	$1.9M	$3.5M
Contractual receivables - net	$9.7M	$12.6M	$11.9M	$8.2M
Other receivables and lease inducements	$278.6M	$249.3M	$214.7M	$177.8M
Goodwill	$644.6M	$643.7M	$643.9M	$643.2M
Other assets	$229.4M	$189.5M	$147.7M	$273.0M
Total assets	$10.0B	$9.9B	$9.1B	$9.4B
Revolving credit facility	$242.0M	—	$20.4M	$19.2M
Senior notes and other unsecured borrowings - net	$4.0B	$4.6B	$5.0B	$4.9B
Accrued expenses and other liabilities	$352.5M	$328.2M	$287.8M	$315.0M
Total liabilities	$4.6B	$5.2B	$5.4B	$5.6B
Common stock $0.10 par value authorized - 700,000 shares, issued and outstanding - 295,539 shares as of December 31, 2025 and 279,129 shares as of December 31, 2024	29.6M	27.9M	24.5M	23.4M
Additional paid-in capital	$8.7B	$7.9B	$6.7B	$6.3B
Cumulative net earnings	$4.7B	$4.1B	$3.7B	$3.4B
Cumulative dividends paid	($8.3B)	($7.5B)	($6.8B)	($6.2B)
Accumulated other comprehensive income	$79.0M	$22.7M	$29.3M	$20.3M
Total stockholders' equity	$5.2B	$4.5B	$3.6B	$3.6B
Noncontrolling interest	$259.2M	$194.2M	$187.7M	$193.9M
Total equity	$5.4B	$4.7B	$3.8B	$3.8B
Total liabilities and equity	$10.0B	$9.9B	$9.1B	$9.4B

Omega Healthcare Investors Inc balance sheet, quarters

Line item	Jun 30, 2026	Mar 31, 2026	Sep 30, 2025	Jun 30, 2025
Buildings and improvements	$7.7B	$7.7B	$7.9B	$7.9B
Land	$1.2B	$1.2B	$1.2B	$1.2B
Furniture and equipment	$534.3M	$531.0M	$538.2M	$539.3M
Construction in progress	$16.8M	$12.0M	$10.5M	$9.4M
Total real estate assets	$9.5B	$9.4B	$9.6B	$9.6B
Less accumulated depreciation	($3.0B)	($2.9B)	($2.9B)	($2.8B)
Real estate assets - net	$6.5B	$6.5B	$6.7B	$6.8B
Real estate loans receivable - net	$1.4B	$1.4B	$1.4B	$1.4B
Investments in unconsolidated entities	$501.2M	$507.7M	$150.3M	$85.4M
Total real estate investments	$8.3B	$8.6B	$8.3B	$8.3B
Non-real estate loans receivable - net	$270.2M	$355.0M	$339.7M	$333.3M
Total investments	$8.6B	$9.0B	$8.6B	$8.6B
Cash and cash equivalents	$39.0M	$26.1M	$737.2M	$734.2M
Restricted cash	$145.2M	$27.2M	$37.8M	$38.4M
Contractual and other receivables - net	$276.1M	$292.1M	—	—
Goodwill	$644.4M	$644.4M	$644.6M	$644.9M
Other assets	$303.5M	$289.2M	$250.6M	$217.2M
Total assets	$10.0B	$10.2B	$10.6B	$10.5B
Revolving credit facility	$6.0M	$425.0M	—	$0
Senior notes and other unsecured borrowings - net	$4.0B	$4.0B	$4.7B	$4.7B
Accrued expenses and other liabilities	$347.9M	$338.2M	$357.4M	$357.0M
Total liabilities	$4.4B	$4.8B	$5.4B	$5.4B
Common stock $0.10 par value authorized - 700,000 shares, issued and outstanding - 299,111 shares as of June 30, 2026 and 295,539 shares as of December 31, 2025	29.9M	29.8M	29.6M	29.3M
Additional paid-in capital	$8.8B	$8.8B	$8.5B	$8.4B
Cumulative net earnings	$5.2B	$4.8B	$4.5B	$4.3B
Cumulative dividends paid	($8.7B)	($8.5B)	($8.1B)	($7.9B)
Accumulated other comprehensive income	$58.1M	$54.0M	$77.0M	$96.8M
Total stockholders' equity	$5.4B	$5.2B	$5.0B	$5.0B
Noncontrolling interest	$251.8M	$263.5M	$207.9M	$200.7M
Total equity	$5.6B	$5.5B	$5.2B	$5.2B
Total liabilities and equity	$10.0B	$10.2B	$10.6B	$10.5B

Cash flow statement

Omega Healthcare Investors Inc cash flow statement, fiscal years

Line item	Dec 31, 2025 · FY	Dec 31, 2024 · FY	Dec 31, 2023 · FY	Dec 31, 2022 · FY
Net income	$609.5M	$417.8M	$248.8M	$438.8M
Depreciation and amortization	$325.2M	$304.6M	$319.7M	$332.4M
Impairment on real estate properties	$22.6M	$23.8M	$91.9M	$38.5M
Straight-line rent and other write-offs	$28.0M	—	—	—
Provision (recovery) for credit losses	$2.3M	($15.5M)	$44.6M	$68.7M
Amortization of deferred financing costs and loss on debt extinguishment	$968.0K	$12.1M	$14.2M	$13.3M
Stock-based compensation expense	$44.2M	$36.7M	$35.1M	$27.3M
Gain on assets sold - net	($67.3M)	($13.2M)	($79.7M)	($360.0M)
Straight-line rent and effective interest receivables	($50.3M)	($43.0M)	($41.8M)	—
Interest paid-in-kind	($13.6M)	($11.5M)	($11.4M)	($9.4M)
Loss from unconsolidated entities	$6.1M	$1.9M	$182.0K	$455.0K
Other non-cash items	($26.3M)	—	—	—
Contractual receivables	$2.9M	($845.0K)	($3.7M)	$3.0M
Lease inducements	($9.0M)	($61.0K)	($15.2M)	$6.0M
Other operating assets and liabilities	$3.2M	$33.8M	$3.8M	$6.5M
Net cash provided by operating activities	$878.6M	$749.4M	$617.7M	$625.7M
Acquisition of real estate	($683.0M)	($408.6M)	($262.5M)	($230.0M)
Net proceeds from sale of real estate investments	$282.8M	$95.0M	$585.0M	$759.0M
Investments in construction in progress	($33.6M)	($69.0M)	($44.5M)	($17.1M)
Investment in loan receivables and other	($173.6M)	($470.0M)	($420.6M)	($372.0M)
Collection of loan principal	$246.6M	$207.6M	$165.2M	$345.7M
Investments in unconsolidated entities	($122.1M)	($971.0K)	($12.3M)	($113.0K)
Distributions from unconsolidated entities in excess of earnings	$12.9M	$1.0M	$8.8M	$3.3M
Capital improvements to real estate investments	($80.9M)	($37.8M)	($38.0M)	($47.2M)
Proceeds from foreign currency forward contracts	$4.2M	$8.4M	$11.4M	—
Receipts from insurance proceeds	$6.8M	$3.1M	$6.8M	$1.3M
Net cash used in investing activities	($539.8M)	($671.2M)	($770.0K)	$442.9M
Proceeds from long-term borrowings	$1.3B	$657.8M	$507.1M	$597.4M
Payments of long-term borrowings	($1.9B)	($1.1B)	($735.0M)	($589.3M)
Payments of financing related costs	($27.3M)	($7.0M)	($3.8M)	($389.0K)
Net proceeds from issuance of common stock	$606.8M	$1.2B	$336.4M	$8.1M
Dividends paid	($780.4M)	($685.4M)	($643.9M)	($632.9M)
(Payments for) proceeds from derivative instruments	($2.2M)	—	—	—
Redemption of Omega OP Units	($6.2M)	($684.0K)	($77.0K)	($9.7M)
Distributions to Omega OP Unit Holders	($43.9M)	($29.3M)	($26.4M)	($20.5M)
Net cash (used in) provided by financing activities	($838.3M)	$26.3M	($473.3M)	($789.4M)
Effect of foreign currency translation on cash, cash equivalents and restricted cash	$5.3M	($580.0K)	$430.0K	($2.9M)
(Decrease) increase in cash, cash equivalents and restricted cash	($494.2M)	$104.0M	$144.1M	$276.2M
Cash, cash equivalents and restricted cash at beginning of period	$548.7M	$444.7M	$300.6M	$24.4M
Cash, cash equivalents and restricted cash at end of period	$54.6M	$548.7M	$444.7M	$300.6M

Omega Healthcare Investors Inc cash flow statement, quarters

Line item	Jun 30, 2026 · YTD	Mar 31, 2026 · Q1	Sep 30, 2025 · YTD	Jun 30, 2025 · YTD
Net income	$538.2M	$158.6M	$437.5M	$252.5M
Depreciation and amortization	$166.0M	$84.1M	$242.5M	$160.4M
Impairment on real estate properties	$392.0K	$392.0K	$16.6M	$15.4M
Straight-line rent and other write-offs	$9.8M	$2.4M	$27.5M	$27.5M
(Recovery) provision for credit losses	($8.3M)	($3.3M)	($3.6M)	$321.0K
Amortization of deferred financing costs and loss on debt extinguishment	$6.8M	$3.4M	$3.5M	$2.4M
Stock-based compensation expense	$34.0M	$10.6M	$34.3M	$25.0M
Gain on assets sold - net	($249.5M)	($3.0M)	($61.2M)	($33.0M)
Straight-line receivables	($23.0M)	($13.2M)	—	—
Interest paid-in-kind	($11.9M)	($6.6M)	($9.3M)	($5.0M)
Loss from unconsolidated entities	$2.3M	$3.0K	$5.7M	$3.1M
Other non-cash items	$8.6M	$522.0K	($10.5M)	($4.4M)
Contractual receivables	($1.8M)	($3.0M)	$53.0K	$1.1M
Other operating assets and liabilities	($38.3M)	($15.5M)	$11.2M	$8.8M
Net cash provided by operating activities	$433.2M	$215.5M	$647.9M	$421.2M
Acquisition of real estate	($226.1M)	($125.0M)	($627.8M)	($560.4M)
Net proceeds from sale of real estate investments	$559.7M	$34.5M	$264.1M	$183.0M
Investments in construction in progress	($7.9M)	($4.1M)	($31.5M)	($29.7M)
Investment in loan receivables and other	($142.0M)	($112.2M)	($140.9M)	($109.8M)
Collection of loan principal	$209.1M	$36.7M	$120.4M	$100.3M
Investments in unconsolidated entities	($97.2M)	($97.0M)	($77.2M)	($1.3M)
Distributions from unconsolidated entities in excess of earnings	$6.7M	$3.4M	$10.0M	$1.5M
Capital improvements to real estate investments	($26.7M)	($8.8M)	($54.2M)	($32.9M)
Proceeds from foreign currency forward contracts	$978.0K	$735.0K	$4.7M	$4.7M
Receipts from insurance proceeds	$5.4M	$1.7M	$4.5M	$392.0K
Net cash provided by (used in) investing activities	$282.0M	($270.0M)	($528.1M)	($444.3M)
Proceeds from borrowings	$1.1B	$719.0M	$670.7M	$670.7M
Payments of borrowings	($1.4B)	($536.0M)	($528.5M)	($527.2M)
Payments of financing related costs	($333.0K)	($333.0K)	($25.6M)	($6.5M)
Net proceeds from issuance of common stock	$166.3M	$104.9M	$606.8M	$517.9M
Dividends paid	($398.4M)	($198.4M)	($582.0M)	($383.8M)
Redemption of Omega OP Units	($83.9M)	($13.3M)	($5.8M)	($3.7M)
Distributions to Omega OP Unit Holders	($32.5M)	($21.5M)	($33.5M)	($26.1M)
Net cash (used in) provided by financing activities	($584.8M)	$54.3M	$102.2M	$241.3M
Effect of foreign currency translation on cash, cash equivalents and restricted cash	($800.0K)	($1.1M)	$4.2M	$5.7M
Increase in cash, cash equivalents and restricted cash	$129.6M	($1.2M)	$226.3M	$223.8M
Cash, cash equivalents and restricted cash at beginning of period	$54.6M	$54.6M	$548.7M	$548.7M
Cash, cash equivalents and restricted cash at end of period	$184.2M	$53.3M	$775.0M	$772.6M

Omega Healthcare Investors Inc score and earnings-call analysis · All covered companies

Figures as reported in SEC filings. General information, not investment advice.